{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:50:51Z","timestamp":1791345051021,"version":"4.3.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173616, 72342015, 82330107"],"award-info":[{"award-number":["82173616, 72342015, 82330107"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Capital's Funds for Health Improvement and Research","award":["2024-1G-4251"],"award-info":[{"award-number":["2024-1G-4251"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3602901, 2023YFC2507200"],"award-info":[{"award-number":["2022YFC3602901, 2023YFC2507200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"DOI":"10.1186\/s40959-026-00531-w","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:06:39Z","timestamp":1783425999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Burden of cardiovascular diseases in breast cancer survivors: a 9-year retrospective cohort study based on regional medical data in Inner Mongolia China"],"prefix":"10.1186","volume":"12","author":[{"given":"Qiaorui","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"6","key":"531_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"41","key":"531_CR2","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43(41):4229\u2013361.","journal-title":"Eur Heart J"},{"issue":"8","key":"531_CR3","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1161\/CIR.0000000000000556","volume":"137","author":"LS Mehta","year":"2018","unstructured":"Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, et al. Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association. Circulation. 2018;137(8):e30\u201366.","journal-title":"Circulation"},{"issue":"1","key":"531_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tcm.2019.01.006","volume":"30","author":"A Padegimas","year":"2020","unstructured":"Padegimas A, Clasen S, Ky B. Cardioprotective strategies to prevent breast cancer therapy-induced cardiotoxicity. Trends Cardiovasc Med. 2020;30(1):22\u20138.","journal-title":"Trends Cardiovasc Med"},{"key":"531_CR5","doi-asserted-by":"publisher","first-page":"114599","DOI":"10.1016\/j.bcp.2021.114599","volume":"190","author":"M Nonaka","year":"2021","unstructured":"Nonaka M, Hosoda H, Uezono Y. Cancer treatment-related cardiovascular disease: Current status and future research priorities. Biochem Pharmacol. 2021;190:114599.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"531_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40880-018-0343-7","volume":"38","author":"B Liu","year":"2018","unstructured":"Liu B, An T, Li M, Yi Z, Li C, Sun X, et al. The association between early-onset cardiac events caused by neoadjuvant or adjuvant chemotherapy in triple-negative breast cancer patients and some novel autophagy-related polymorphisms in their genomic DNA: a real-world study. Cancer Commun (Lond). 2018;38(1):71.","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"531_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/jan.14571","volume":"77","author":"J Li","year":"2021","unstructured":"Li J, Qiang WM, Wang Y, Wang XY. Development and validation of a risk assessment nomogram for venous thromboembolism associated with hospitalized postoperative Chinese breast cancer patients. J Adv Nurs. 2021;77(1):473\u201383.","journal-title":"J Adv Nurs"},{"key":"531_CR8","unstructured":"Statistical Bulletin of National Economic and Social Development of Inner Mongolia Autonomous Region. in 2023. https:\/\/www.nmg.gov.cn\/tjsj\/sjfb\/tjsj\/tjgb\/202403\/t20240321_2483646.html."},{"key":"531_CR9","doi-asserted-by":"publisher","unstructured":"Chen J, Qiao L, Qi M, Zhang Y, Yan Y, Kang W et al. Higher disease burden and lower utilization in mongolian with breast cancer: a 9-year retrospective cohort study of 18.19 million adults in China. Int J Surg. 2024;110(8):4588\u201397. https:\/\/doi.org\/10.1097\/JS9.0000000000001478.","DOI":"10.1097\/JS9.0000000000001478"},{"issue":"9","key":"531_CR10","doi-asserted-by":"publisher","first-page":"e2231182","DOI":"10.1001\/jamanetworkopen.2022.31182","volume":"5","author":"HZ Zhou","year":"2022","unstructured":"Zhou HZ, Qiao LY, Zhang YJ, Kang WW, Yan X, Jiang YL, et al. Association of Ethnicity, Sex, and Age With Cancer Diagnoses and Health Care Utilization Among Children in Inner Mongolia, China. JAMA Netw Open. 2022;5(9):e2231182.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"531_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/ejhf.654","volume":"19","author":"JL Zamorano","year":"2017","unstructured":"Zamorano JL, Lancellotti P, Rodriguez Mu\u00f1oz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur J Heart Fail. 2017;19(1):9\u201342.","journal-title":"Eur J Heart Fail"},{"issue":"25","key":"531_CR12","doi-asserted-by":"publisher","first-page":"e1082","DOI":"10.1161\/CIR.0000000000000625","volume":"139","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS. AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1082\u2013e143.","journal-title":"Circulation"},{"key":"#cr-split#-531_CR13.1","unstructured":"Organization WH. Cardiovascular Diseases (CVDs) 2021 [updated 2021-6-11"},{"key":"#cr-split#-531_CR13.2","unstructured":"cited 2021 Dec 14]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)."},{"issue":"7","key":"531_CR14","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1245\/s10434-018-6486-6","volume":"25","author":"AE Giuliano","year":"2018","unstructured":"Giuliano AE, Edge SB, Hortobagyi GN. Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer. Ann Surg Oncol. 2018;25(7):1783\u20135.","journal-title":"Ann Surg Oncol"},{"key":"531_CR15","unstructured":"Bureau IMARS. Annual data of gross regional product - city data in Inner Mongolia Autonomous Region 2021 [updated 2021-03-01. Available from: http:\/\/tj.nmg.gov.cn\/datashow\/easyquery\/easyquery.htm?cn=B0103"},{"issue":"1","key":"531_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10549-013-2521-2","volume":"139","author":"S Nechuta","year":"2013","unstructured":"Nechuta S, Lu W, Zheng Y, Cai H, Bao PP, Gu K, et al. Comorbidities and breast cancer survival: a report from the Shanghai Breast Cancer Survival Study. Breast Cancer Res Treat. 2013;139(1):227\u201335.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"531_CR17","doi-asserted-by":"publisher","first-page":"13682","DOI":"10.1038\/s41598-022-15460-8","volume":"12","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhao J, Jiang N, Liu Y, Wang T, Yu X, et al. The association between comorbidities and stigma among breast cancer survivors. Sci Rep. 2022;12(1):13682.","journal-title":"Sci Rep"},{"issue":"9","key":"531_CR18","doi-asserted-by":"publisher","first-page":"e0184174","DOI":"10.1371\/journal.pone.0184174","volume":"12","author":"NJ Park","year":"2017","unstructured":"Park NJ, Chang Y, Bender C, Conley Y, Chlebowski RT, van Londen GJ, et al. Cardiovascular disease and mortality after breast cancer in postmenopausal women: Results from the Women\u2019s Health Initiative. PLoS ONE. 2017;12(9):e0184174.","journal-title":"PLoS ONE"},{"issue":"10","key":"531_CR19","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1200\/JCO.2015.64.0409","volume":"34","author":"SH Armenian","year":"2016","unstructured":"Armenian SH, Xu L, Ky B, Sun C, Farol LT, Pal SK, et al. Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study. J Clin Oncol. 2016;34(10):1122\u201330.","journal-title":"J Clin Oncol"},{"issue":"10","key":"531_CR20","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1002\/cam4.1754","volume":"7","author":"D Schoormans","year":"2018","unstructured":"Schoormans D, Vissers PAJ, van Herk-Sukel MPP, Denollet J, Pedersen SS, Dalton SO, et al. Incidence of cardiovascular disease up to 13 year after cancer diagnosis: A matched cohort study among 32 757 cancer survivors. Cancer Med. 2018;7(10):4952\u201363.","journal-title":"Cancer Med"},{"issue":"2","key":"531_CR21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jaccao.2022.03.004","volume":"4","author":"NML Battisti","year":"2022","unstructured":"Battisti NML, Welch CA, Sweeting M, de Belder M, Deanfield J, Weston C, et al. Prevalence of Cardiovascular Disease in Patients With Potentially Curable Malignancies: A National Registry Dataset Analysis. JACC CardioOncol. 2022;4(2):238\u201353.","journal-title":"JACC CardioOncol"},{"key":"531_CR22","doi-asserted-by":"publisher","unstructured":"Yang H, Bhoo-Pathy N, Brand JS, Hedayati E, Grassmann F, Zeng E et al. Risk of heart disease following treatment for breast cancer - results from a population-based cohort study. Elife. 2022;11:e71562. https:\/\/doi.org\/10.7554\/eLife.71562.","DOI":"10.7554\/eLife.71562"},{"issue":"1","key":"531_CR23","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1186\/s12885-021-08716-5","volume":"21","author":"M Jakobsen","year":"2021","unstructured":"Jakobsen M, Kolodziejczyk C, Jensen MS, Poulsen PB, Khan H, K\u00fcmler T, et al. Cardiovascular disease in women with breast cancer - a nationwide cohort study. BMC Cancer. 2021;21(1):1040.","journal-title":"BMC Cancer"},{"issue":"2","key":"531_CR24","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s10147-018-1341-0","volume":"24","author":"Y Okura","year":"2019","unstructured":"Okura Y, Takayama T, Ozaki K, Tanaka H, Seki H, Takenouchi T, et al. Burden of cardiovascular disease in Japanese cancer patients and survivors: a single cancer-center study in Niigata City. Int J Clin Oncol. 2019;24(2):196\u2013210.","journal-title":"Int J Clin Oncol"},{"issue":"20","key":"531_CR25","doi-asserted-by":"publisher","first-page":"e026743","DOI":"10.1161\/JAHA.122.026743","volume":"11","author":"JE Kim","year":"2022","unstructured":"Kim JE, Choi J, Park J, Han W, Kang D, Choi JY. Effects of Endocrine Therapy on Cardiovascular Diseases and Type 2 Diabetes Among Breast Cancer Survivors: The National Health Insurance Service Database of Korea. J Am Heart Assoc. 2022;11(20):e026743.","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"531_CR26","first-page":"669","volume":"36","author":"W The","year":"2023","unstructured":"The W. Report on Cardiovascular Health and Diseases in China 2022: an Updated Summary. Biomed Environ Sci. 2023;36(8):669\u2013701.","journal-title":"Biomed Environ Sci"},{"issue":"2","key":"531_CR27","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.athoracsur.2010.03.100","volume":"90","author":"M Onaitis","year":"2010","unstructured":"Onaitis M, D\u2019Amico T, Zhao Y, O\u2019Brien S, Harpole D. Risk factors for atrial fibrillation after lung cancer surgery: analysis of the Society of Thoracic Surgeons general thoracic surgery database. Ann Thorac Surg. 2010;90(2):368\u201374.","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"531_CR28","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/eurheartj\/ehab745","volume":"43","author":"A Guha","year":"2022","unstructured":"Guha A, Fradley MG, Dent SF, Weintraub NL, Lustberg MB, Alonso A, et al. Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis. Eur Heart J. 2022;43(4):300\u201312.","journal-title":"Eur Heart J"},{"issue":"8","key":"531_CR29","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41569-020-0348-1","volume":"17","author":"J Herrmann","year":"2020","unstructured":"Herrmann J. Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia. Nat Rev Cardiol. 2020;17(8):474\u2013502.","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"531_CR30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.6004\/jnccn.2020.7629","volume":"19","author":"AA Matthews","year":"2021","unstructured":"Matthews AA, Peacock Hinton S, Stanway S, Lyon AR, Smeeth L, Bhaskaran K, et al. Risk of Cardiovascular Diseases Among Older Breast Cancer Survivors in the United States: A Matched Cohort Study. J Natl Compr Canc Netw. 2021;19(3):275\u201384.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"531_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1377\/hlthaff.26.1.38","volume":"26","author":"GA Mensah","year":"2007","unstructured":"Mensah GA, Brown DW. An Overview Of Cardiovascular Disease Burden In The United States. Health Aff. 2007;26(1):38\u201348.","journal-title":"Health Aff"},{"key":"531_CR32","doi-asserted-by":"publisher","unstructured":"Szczepaniak P, Siedlinski M, Hodorowicz-Zaniewska D, Nosalski R, Mikolajczyk TP, Dobosz AM et al. Breast cancer chemotherapy induces vascular dysfunction and hypertension through a NOX4-dependent mechanism. J Clin Invest. 2022;132(13):e149117. https:\/\/doi.org\/10.1172\/JCI149117.","DOI":"10.1172\/JCI149117"},{"issue":"4","key":"531_CR33","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/eurheartj\/ehab807","volume":"43","author":"JL Merino","year":"2022","unstructured":"Merino JL. Atrial fibrillation and breast cancer: casual or causal relationship? Eur Heart J. 2022;43(4):313\u20135.","journal-title":"Eur Heart J"},{"issue":"5","key":"531_CR34","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"issue":"15","key":"531_CR35","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1200\/JCO.21.01736","volume":"40","author":"H Greenlee","year":"2022","unstructured":"Greenlee H, Iribarren C, Rana JS, Cheng R, Nguyen-Huynh M, Rillamas-Sun E, et al. Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study. J Clin Oncol. 2022;40(15):1647\u201358.","journal-title":"J Clin Oncol"},{"issue":"1","key":"531_CR36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12885-020-06838-w","volume":"20","author":"B Mery","year":"2020","unstructured":"Mery B, Fouilloux A, Rowinski E, Catella-Chatron J, Guichard JB, Da Costa A, et al. Cardiovascular disease events within 5 years after a diagnosis of breast cancer. BMC Cancer. 2020;20(1):337.","journal-title":"BMC Cancer"},{"issue":"1","key":"531_CR37","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1186\/s12885-022-10314-y","volume":"22","author":"TL Yeh","year":"2022","unstructured":"Yeh TL, Hsu MS, Hsu HY, Tsai MC, Jhuang JR, Chiang CJ, et al. Risk of cardiovascular diseases in cancer patients: A nationwide representative cohort study in Taiwan. BMC Cancer. 2022;22(1):1198.","journal-title":"BMC Cancer"},{"issue":"6","key":"531_CR38","doi-asserted-by":"publisher","first-page":"e13754","DOI":"10.1111\/eci.13754","volume":"52","author":"YX Gue","year":"2022","unstructured":"Gue YX, Bisson A, Bodin A, Herbert J, Lip GYH, Fauchier L. Breast cancer and incident cardiovascular events: A systematic analysis at the nationwide level. Eur J Clin Invest. 2022;52(6):e13754.","journal-title":"Eur J Clin Invest"},{"issue":"41","key":"531_CR39","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC). Eur Heart J. 2022;43(41):4229\u2013361.","journal-title":"Eur Heart J"},{"issue":"5","key":"531_CR40","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ana.25227","volume":"83","author":"BB Navi","year":"2018","unstructured":"Navi BB, Iadecola C. Ischemic stroke in cancer patients: A review of an underappreciated pathology. Ann Neurol. 2018;83(5):873\u201383.","journal-title":"Ann Neurol"},{"issue":"6","key":"531_CR41","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1002\/cam4.2184","volume":"8","author":"X Yin","year":"2019","unstructured":"Yin X, Xu Y, Man X, Liu L, Jiang Y, Zhao L, et al. Direct costs of both inpatient and outpatient care for all type cancers: The evidence from Beijing, China. Cancer Med. 2019;8(6):3250\u201360.","journal-title":"Cancer Med"},{"issue":"7","key":"531_CR42","first-page":"1225","volume":"42","author":"W Liu","year":"2021","unstructured":"Liu W, Wang LJ, Qi JL, Liu JM, You JL, Lin L, et al. [Disease burden of breast cancer in women in China, 1990\u20132017]. Zhonghua Liu Xing Bing Xue Za Zhi. 2021;42(7):1225\u201330.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"10","key":"531_CR43","doi-asserted-by":"publisher","first-page":"e008406","DOI":"10.1161\/CIRCHEARTFAILURE.121.008406","volume":"14","author":"H Wang","year":"2021","unstructured":"Wang H, Chai K, Du M, Wang S, Cai JP, Li Y, et al. Prevalence and Incidence of Heart Failure Among Urban Patients in China: A National Population-Based Analysis. Circ Heart Fail. 2021;14(10):e008406.","journal-title":"Circ Heart Fail"},{"issue":"3","key":"531_CR44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.whi.2004.11.006","volume":"15","author":"AC Sasser","year":"2005","unstructured":"Sasser AC, Rousculp MD, Birnbaum HG, Oster EF, Lufkin E, Mallet D. Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population. Womens Health Issues. 2005;15(3):97\u2013108.","journal-title":"Womens Health Issues"},{"issue":"5","key":"531_CR45","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s40273-021-01014-9","volume":"39","author":"A Palacios","year":"2021","unstructured":"Palacios A, Rojas-Roque C, Gonz\u00e1lez L, Bardach A, Ciapponi A, Peckaitis C, et al. Direct Medical Costs, Productivity Loss Costs and Out-Of-Pocket Expenditures in Women with Breast Cancer in Latin America and the Caribbean: A Systematic Review. PharmacoEconomics. 2021;39(5):485\u2013502.","journal-title":"PharmacoEconomics"},{"key":"531_CR46","unstructured":"https:\/\/www.shujujidi.com\/caijing\/1492.html."},{"issue":"2","key":"531_CR47","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10549-020-05634-1","volume":"181","author":"DL Hershman","year":"2020","unstructured":"Hershman DL, Till C, Wright JD, Accordino M, Vaidya R, Barlow WE, et al. Healthcare utilization and cost of care in elderly breast cancer patients enrolled in SWOG clinical trials. Breast Cancer Res Treat. 2020;181(2):455\u201363.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"531_CR48","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12872-022-02697-4","volume":"22","author":"A Guha","year":"2022","unstructured":"Guha A, Jain A, Aggarwal A, Dey AK, Dani S, Ganatra S, et al. Length of stay and cost of care associated with admissions for atrial fibrillation among patients with cancer. BMC Cardiovasc Disord. 2022;22(1):272.","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"531_CR49","first-page":"309","volume":"66","author":"G Curigliano","year":"2016","unstructured":"Curigliano G, Cardinale D, Dent S, Criscitiello C, Aseyev O, Lenihan D, et al. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management. CA Cancer J Clin. 2016;66(4):309\u201325.","journal-title":"CA Cancer J Clin"},{"key":"531_CR50","doi-asserted-by":"publisher","first-page":"869529","DOI":"10.3389\/fonc.2022.869529","volume":"12","author":"E Kimpe","year":"2022","unstructured":"Kimpe E, Werbrouck A, De Ridder M, Putman K. Quantifying Societal Burden of Radiation-Induced Cardiovascular Events in Breast Cancer Survivors. Front Oncol. 2022;12:869529.","journal-title":"Front Oncol"},{"issue":"7","key":"531_CR51","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.repce.2021.07.016","volume":"40","author":"F de Mello Sampayo","year":"2021","unstructured":"de Mello Sampayo F, Fiuza M, Pinto F, Fontes J. Cost-effectiveness of cardio-oncology clinical assessment for prevention of chemotherapy-induced cardiotoxicity. Revista Portuguesa de Cardiologia (English Edition). 2021;40(7):475\u201383.","journal-title":"Revista Portuguesa de Cardiologia (English Edition)"},{"issue":"6","key":"531_CR52","first-page":"577","volume":"5","author":"J Chen","year":"2025","unstructured":"Chen J, Qiao L, Yan Y, Qi M, Zhang Y, Kang W, et al. Do ethnic disparities exist in disease burden and healthcare utilization of male breast cancer? A 9-year cohort study of 9.08 million adults in China. J Natl Cancer Cent. 2025;5(6):577\u201385.","journal-title":"J Natl Cancer Cent"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-026-00531-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00531-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00531-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:18:00Z","timestamp":1791343080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40959-026-00531-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["531"],"URL":"https:\/\/doi.org\/10.1186\/s40959-026-00531-w","relation":{},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"5 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study received ethics approval from the Medical Ethics Committee of the Inner Mongolia Center for Disease Control and Prevention (NMCDCIRB2021001). Informed consent from participants was approved for exemption.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"120"}}